Clinical Trial Update: Biomarker-Linked Outcomes of Cellcept in Lupus Arthritis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update for Cellcept (mycophenolate mofetil) in systemic lupus erythematosus with arthritis; results completed and posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthritis
• Systemic Lupus Erythematosus

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)

Snippet

Sponsor: Oklahoma Medical Research Foundation | Conditions: Systemic Lupus Erythematosus, Arthritis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-10-09